A client presents with signs of hemolysis, including jaundice and an elevated bilirubin level. Which type of anemia is most likely to be associated with these findings?

A) This choice is incorrect because ESA therapy is not typically associated with hypotension. In fact, an increase in blood pressure is a potential side effect of ESAs.

B) This choice is incorrect because hypokalemia (low potassium levels) is not a common adverse effect of ESA therapy.

C) This choice is incorrect because hypoglycemia (low blood sugar) is not a typical side effect of ESA therapy.

D) This choice is correct. ESA therapy can increase the risk of thrombosis (blood clot formation) due to the stimulation of red blood cell production. Clients receiving ESAs should be monitored for signs of thrombosis, such as swelling, pain, and redness in the extremities.

A) This choice is incorrect because monitoring the client's temperature is important, but it is not the priority during the PRBC transfusion process.

B) This choice is incorrect because administering pain medication may be necessary if the client is experiencing discomfort during or after the transfusion, but it is not the priority action.

C) This choice is incorrect because obtaining informed consent is an essential step before any medical intervention, including transfusions, but it is not the priority during the transfusion process.

D) This choice is correct. Checking the client's blood type is a priority before administering a PRBC transfusion to ensure compatibility and prevent adverse reactions. Transfusion reactions can be life-threatening, so verifying the blood type is crucial for client safety.